Schonfeld Strategic Advisors LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2024$500,544
+134.7%
535,800
+42.0%
0.00%
+200.0%
Q4 2023$213,231
+200.3%
377,400
+216.6%
0.00%0.0%
Q3 2023$70,995
+285.7%
119,200
+272.5%
0.00%
Q2 2023$18,405
+5.2%
32,000
+28.5%
0.00%
Q1 2023$17,501
-93.8%
24,900
-80.0%
0.00%
-100.0%
Q4 2022$281,829
-58.6%
124,703
-41.3%
0.00%
-66.7%
Q3 2022$680,000
+129.0%
212,417
+171.6%
0.01%
+100.0%
Q2 2022$297,000
-46.2%
78,200
+91.6%
0.00%
-40.0%
Q4 2021$552,000
-85.0%
40,810
-80.1%
0.01%
-87.2%
Q3 2021$3,687,000
+265.0%
205,309
+249.0%
0.04%
+254.5%
Q2 2021$1,010,000
+4.8%
58,829
+22.1%
0.01%
-8.3%
Q1 2021$964,000
-60.7%
48,199
-54.5%
0.01%
-63.6%
Q2 2020$2,456,000
+170.8%
106,014
+112.9%
0.03%
+22.2%
Q3 2019$907,000
-59.0%
49,800
+139.4%
0.03%
-83.7%
Q1 2018$2,211,000
+489.6%
20,804
-4.6%
0.17%
+159.4%
Q3 2016$375,00021,8030.06%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders